News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Spark Therapeutics
NEWS
JOBS
IN THE PRESS
NEWS
Business
Biogen Taps Former Spark Therapeutics Exec and a Finance Vet for Hemophilia Spin-off Company Bioverativ
November 15, 2016
·
3 min read
Shire Kills Baxalta’s Hemophilia B Program; Clears Path for BioMarin, Spark Therapeutics and uniQure
August 3, 2016
·
3 min read
Job Trends
Spark Therapeutics Expands Into Boston Following One of the Biggest IPOs of the Year
November 4, 2015
·
2 min read
Drug Development
Spark Therapeutics Attempts to Quell Investor’s Nerves About Changes to Clinical Trial
September 11, 2015
·
2 min read
Deals
Gene Therapy Biotech Spark Therapeutics Sets Terms for $86 Million IPO
December 31, 2014
·
2 min read
Business
Spark Therapeutics Strikes $280 Million Hemophilia B Pact With Pfizer
December 8, 2014
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Business
Spark Therapeutics Enters Into Strategic Collaboration with Neurochase for Use of Proprietary Delivery Technology for CNS Disorders
January 27, 2023
·
2 min read
Drug Development
Spark Therapeutics Announces Updated Phase 1/2 Study Results Supporting the Durability of Investigational Gene Therapy SPK-8011 in Patients With Hemophilia A
December 12, 2022
·
5 min read
Business
Spark Therapeutics Announces Departure of CEO and Founder Jeff Marrazzo; COO Ron Philip Named as Successor
February 23, 2022
·
4 min read
Pharm Country
Spark Therapeutics to Invest $575M in New 500k Square Foot State-of-the-Art Gene Therapy Innovation Center on Drexel’s University City Campus
December 17, 2021
·
7 min read
Drug Development
Spark Therapeutics Updated SPK-8011 Data from Phase 1/2 Study Shows Multi-Year, Durable Factor VIII (FVIII) Expression that Significantly Reduced Bleeding in Hemophilia A Patients
November 17, 2021
·
4 min read
Business
Spark Therapeutics and CombiGene Enter into Exclusive, Global Licensing Agreement for Gene Therapy Candidate CG01
October 12, 2021
·
3 min read
Pharm Country
NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington’s Disease
September 7, 2021
·
5 min read
Business
Spark Therapeutics Enters Collaboration with Senti Bio to Bolster Industry-Leading Gene Therapy Research Platform
April 13, 2021
·
4 min read
Business
Senti Bio Enters Collaboration with Spark Therapeutics to Develop Next-Generation Precision Gene Therapies
April 13, 2021
·
3 min read
Business
Spark Therapeutics Further Strengthens Technical Expertise with Appointment of Cynthia Pussinen as Chief Technical Officer
February 25, 2021
·
2 min read
